Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)
CNY 7.27
(-0.27%)
CNY 7.27
(-0.27%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 150 Million CNY | 5560.38% |
| 2022 | 2.65 Million CNY | 0.0% |
| 2021 | 2.65 Million CNY | 0.0% |
| 2020 | 2.65 Million CNY | -97.88% |
| 2019 | 125 Million CNY | -72.22% |
| 2018 | 450 Million CNY | 8438.9% |
| 2017 | 5.27 Million CNY | -98.92% |
| 2016 | 490 Million CNY | -56.36% |
| 2015 | 1.12 Billion CNY | 84.67% |
| 2014 | 608 Million CNY | 12.73% |
| 2013 | 539.35 Million CNY | 69.74% |
| 2012 | 317.75 Million CNY | 47.79% |
| 2011 | 215 Million CNY | -34.96% |
| 2010 | 330.57 Million CNY | -32.82% |
| 2009 | 492.07 Million CNY | -16.78% |
| 2008 | 591.27 Million CNY | -0.48% |
| 2007 | 594.12 Million CNY | 13.87% |
| 2006 | 521.77 Million CNY | 35.16% |
| 2005 | 386.05 Million CNY | 4.06% |
| 2004 | 371 Million CNY | 24.2% |
| 2003 | 298.7 Million CNY | 466.79% |
| 2002 | 52.7 Million CNY | 1546.88% |
| 2001 | 3.2 Million CNY | -5.88% |
| 2000 | 3.4 Million CNY | -94.36% |
| 1999 | 60.23 Million CNY | 58.51% |
| 1998 | 38 Million CNY | 25.5% |
| 1997 | 30.28 Million CNY | 60.64% |
| 1996 | 18.85 Million CNY | 0.0% |
| 1995 | - CNY | 0.0% |
| 1994 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 230 Million CNY | 53.33% |
| 2024 Q3 | 492.74 Million CNY | 37.26% |
| 2024 Q2 | 359 Million CNY | 56.09% |
| 2023 FY | 150 Million CNY | 5560.38% |
| 2023 Q2 | 70 Million CNY | 0.0% |
| 2023 Q4 | 150 Million CNY | 0.0% |
| 2023 Q3 | 150 Million CNY | 114.29% |
| 2023 Q1 | - CNY | -100.0% |
| 2022 Q2 | 2.65 Million CNY | 0.0% |
| 2022 FY | 2.65 Million CNY | 0.0% |
| 2022 Q4 | 2.65 Million CNY | 0.0% |
| 2022 Q1 | 2.65 Million CNY | 0.0% |
| 2022 Q3 | 2.65 Million CNY | 0.0% |
| 2021 FY | 2.65 Million CNY | 0.0% |
| 2021 Q1 | 2.65 Million CNY | 0.0% |
| 2021 Q2 | 2.65 Million CNY | 0.0% |
| 2021 Q4 | 2.65 Million CNY | 0.0% |
| 2021 Q3 | 2.65 Million CNY | 0.0% |
| 2020 FY | 2.65 Million CNY | -97.88% |
| 2020 Q3 | 2.65 Million CNY | -99.34% |
| 2020 Q1 | 400 Million CNY | 220.0% |
| 2020 Q2 | 400 Million CNY | 0.0% |
| 2020 Q4 | 2.65 Million CNY | 0.0% |
| 2019 FY | 125 Million CNY | -72.22% |
| 2019 Q4 | 125 Million CNY | 4.17% |
| 2019 Q1 | 700 Million CNY | 55.56% |
| 2019 Q2 | 550 Million CNY | -21.43% |
| 2019 Q3 | 120 Million CNY | -78.18% |
| 2018 Q2 | 500 Million CNY | 9387.67% |
| 2018 Q1 | 5.27 Million CNY | 0.0% |
| 2018 Q4 | 450 Million CNY | 12.5% |
| 2018 FY | 450 Million CNY | 8438.9% |
| 2018 Q3 | 400 Million CNY | -20.0% |
| 2017 Q2 | 428 Million CNY | -4.68% |
| 2017 Q3 | 228 Million CNY | -46.73% |
| 2017 Q1 | 449 Million CNY | -8.37% |
| 2017 Q4 | 5.27 Million CNY | -97.69% |
| 2017 FY | 5.27 Million CNY | -98.92% |
| 2016 Q3 | 672 Million CNY | -44.28% |
| 2016 Q1 | 1.12 Billion CNY | 0.06% |
| 2016 Q2 | 1.2 Billion CNY | 7.35% |
| 2016 Q4 | 490 Million CNY | -27.08% |
| 2016 FY | 490 Million CNY | -56.36% |
| 2015 Q4 | 1.12 Billion CNY | 29.95% |
| 2015 Q2 | 774 Million CNY | 27.3% |
| 2015 FY | 1.12 Billion CNY | 84.67% |
| 2015 Q1 | 608 Million CNY | 0.0% |
| 2015 Q3 | 864 Million CNY | 11.63% |
| 2014 Q2 | 640 Million CNY | 49.06% |
| 2014 Q4 | 608 Million CNY | -10.85% |
| 2014 Q3 | 682 Million CNY | 6.56% |
| 2014 Q1 | 429.35 Million CNY | -20.39% |
| 2014 FY | 608 Million CNY | 12.73% |
| 2013 Q2 | 417.67 Million CNY | 13.7% |
| 2013 FY | 539.35 Million CNY | 69.74% |
| 2013 Q4 | 539.35 Million CNY | 10.6% |
| 2013 Q1 | 367.35 Million CNY | 15.61% |
| 2013 Q3 | 487.67 Million CNY | 16.76% |
| 2012 FY | 317.75 Million CNY | 47.79% |
| 2012 Q4 | 317.75 Million CNY | 39.98% |
| 2012 Q3 | 227 Million CNY | 15.23% |
| 2012 Q2 | 197 Million CNY | -8.37% |
| 2012 Q1 | 215 Million CNY | 0.0% |
| 2011 FY | 215 Million CNY | -34.96% |
| 2011 Q2 | 318.57 Million CNY | -3.63% |
| 2011 Q3 | 256.15 Million CNY | -19.59% |
| 2011 Q4 | 215 Million CNY | -16.07% |
| 2011 Q1 | 330.57 Million CNY | 0.0% |
| 2010 FY | 330.57 Million CNY | -32.82% |
| 2010 Q1 | 452.07 Million CNY | -8.13% |
| 2010 Q2 | 403.07 Million CNY | -10.84% |
| 2010 Q3 | 353.07 Million CNY | -12.4% |
| 2010 Q4 | 330.57 Million CNY | -6.37% |
| 2009 Q4 | 492.07 Million CNY | -9.54% |
| 2009 Q3 | 543.97 Million CNY | -7.84% |
| 2009 Q1 | 591.27 Million CNY | 0.0% |
| 2009 Q2 | 590.27 Million CNY | -0.17% |
| 2009 FY | 492.07 Million CNY | -16.78% |
| 2008 FY | 591.27 Million CNY | -0.48% |
| 2008 Q1 | 593.52 Million CNY | -0.1% |
| 2008 Q2 | 594.02 Million CNY | 0.08% |
| 2008 Q3 | 592.42 Million CNY | -0.27% |
| 2008 Q4 | 591.27 Million CNY | -0.19% |
| 2007 Q4 | 594.12 Million CNY | 4.28% |
| 2007 Q2 | 535.82 Million CNY | -3.59% |
| 2007 FY | 594.12 Million CNY | 13.87% |
| 2007 Q1 | 555.77 Million CNY | 6.52% |
| 2007 Q3 | 569.72 Million CNY | 6.33% |
| 2006 Q3 | 465.87 Million CNY | 7.27% |
| 2006 Q4 | 521.77 Million CNY | 12.0% |
| 2006 Q1 | 453.3 Million CNY | 17.42% |
| 2006 Q2 | 434.3 Million CNY | -4.19% |
| 2006 FY | 521.77 Million CNY | 35.16% |
| 2005 Q4 | 386.05 Million CNY | -7.6% |
| 2005 Q3 | 417.8 Million CNY | -0.48% |
| 2005 Q2 | 419.8 Million CNY | 13.43% |
| 2005 Q1 | 370.1 Million CNY | -0.24% |
| 2005 FY | 386.05 Million CNY | 4.06% |
| 2004 Q2 | 370 Million CNY | 0.0% |
| 2004 Q3 | 371 Million CNY | 0.27% |
| 2004 Q4 | 371 Million CNY | 0.0% |
| 2004 FY | 371 Million CNY | 24.2% |
| 2004 Q1 | 370 Million CNY | 23.87% |
| 2003 Q2 | 130.95 Million CNY | 2.55% |
| 2003 Q4 | 298.7 Million CNY | 60.2% |
| 2003 Q3 | 186.45 Million CNY | 42.38% |
| 2003 FY | 298.7 Million CNY | 466.79% |
| 2003 Q1 | 127.7 Million CNY | 142.31% |
| 2002 Q4 | 52.7 Million CNY | -19.73% |
| 2002 Q1 | - CNY | -100.0% |
| 2002 FY | 52.7 Million CNY | 1546.88% |
| 2002 Q3 | 65.65 Million CNY | 1951.56% |
| 2002 Q2 | 3.2 Million CNY | 0.0% |
| 2001 FY | 3.2 Million CNY | -5.88% |
| 2001 Q4 | 3.2 Million CNY | 0.0% |
| 2001 Q2 | 4.33 Million CNY | 0.0% |
| 2000 Q2 | 43.4 Million CNY | 0.0% |
| 2000 Q4 | 3.4 Million CNY | 0.0% |
| 2000 FY | 3.4 Million CNY | -94.36% |
| 1999 Q2 | 36.22 Million CNY | 0.0% |
| 1999 FY | 60.23 Million CNY | 58.51% |
| 1999 Q4 | 60.23 Million CNY | 0.0% |
| 1998 Q2 | 88.06 Million CNY | 0.0% |
| 1998 FY | 38 Million CNY | 25.5% |
| 1998 Q4 | 38 Million CNY | 0.0% |
| 1997 FY | 30.28 Million CNY | 60.64% |
| 1997 Q4 | 30.28 Million CNY | 0.0% |
| 1997 Q2 | - CNY | 0.0% |
| 1996 Q4 | 18.85 Million CNY | 0.0% |
| 1996 FY | 18.85 Million CNY | 0.0% |
| 1996 Q2 | - CNY | 0.0% |
| 1995 Q4 | - CNY | 0.0% |
| 1995 FY | - CNY | 0.0% |
| 1995 Q2 | - CNY | 0.0% |
| 1994 FY | - CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 75.17 Million CNY | -99.531% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 1.33 Billion CNY | 88.745% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.03 Billion CNY | 85.523% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 405.85 Million CNY | 63.041% |
| Aurora Optoelectronics Co.,Ltd. | 29.86 Million CNY | -402.192% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 114.76 Million CNY | -30.7% |
| NanJing Pharmaceutical Company Limited | 11.61 Billion CNY | 98.709% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 291.35 Million CNY | 48.517% |